Denali Therapeutics, Inc. (DNLI)
18.51
+0.24
(+1.31%)
USD |
NASDAQ |
Jan 15, 10:45
Denali Therapeutics SG&A Expense (TTM): 127.16M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Enovis Corp. | 1.057B |
| Masimo Corp. | 596.30M |
| Novavax, Inc. | 201.70M |
| Protalix Biotherapeutics, Inc. | 11.16M |
| Twist Bioscience Corp. | 246.98M |